-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

Benzinga·06/15/2026 14:58:44
Listen to the news
BMO Capital analyst Juan Sanabria maintains National Health Investors (NYSE:NHI) with a Outperform and lowers the price target from $90 to $80.